Carcinoma of Unknown Primary — Trials

Carcinoma of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,156
Recruiting: 2,259
Ph III recruiting: 269
Growth YoY: +12.3%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,893)

clinicaltrialsPublishedShowing 401–450 of 4,794 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01783587	Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer	completed	Phase 1	29	Dana-Farber Cancer InstituteOTHER	1	Mar 25, 2026	clinicaltrials
NCT05039177	A Study of ERAS-007 in Patients With Advanced Gastrointestinal Malignancies(HERKULES-3)	completed	Phase 1 / Phase 2	101	Erasca, Inc.INDUSTRY	1	Mar 25, 2026	clinicaltrials